Lipid Nanoparticle-Encapsulated PolyI:C as an Adjuvant Enhances Both Humoral and Cellular Immune Responses to the Hepatitis B Vaccine
<b>Background</b>: Currently marketed hepatitis B vaccines are primarily recombinant protein vaccines. However, their antigen immunogenicity is relatively weak, requiring combination with effective adjuvants to enhance the immune response. The development of novel, highly effective adjuvants is a ke...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2026-04-01
|
| Colección: | Vaccines |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/2076-393X/14/5/397 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|